source
- J&J multiple myeloma drug gains edge in earlier stage diseaseThe latest results studying Talvey in combination with Darzalex Faspro support J&J’s efforts to expand the immunotherapy's use.BioPharma Dive · 1mo ago↗ source
- Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutEli Lilly made a push in blood cancer at this year’s European Hematology Association meeting in Stockholm over the weekend. The drugmaker presented data for Jaypirca combined with the standard of c…Endpoints · 1mo ago↗ source
- Celiac disease is entering a new era of therapeutic innovationFor the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.BioPharma Dive